Damora Therapeutics, Inc.
Recent Filings
All 315 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Winslow Garrett | General Counsel | Sale | 260 @ $3.39 | 1,429 | Jul 3, 2025 |
| Firmani Lori | Interim CFO | Sale | 147 @ $3.39 | 692 | Jul 3, 2025 |
| Winslow Garrett | General Counsel | Sale | 471 @ $5.60 | 1,009 | Jan 3, 2025 |
| Firmani Lori | Interim CFO | Sale | 261 @ $5.63 | 465 | Jan 3, 2025 |
| Schambye Hans T. | Chief Executive Officer | Sale | 1,341 @ $5.60 | 3,397 | Jan 3, 2025 |
| OrbiMed Advisors Israel II Ltd | — | Sale | 248,819 @ $0.75 | 631,048 | Aug 15, 2023 |
| OrbiMed Capital GP VII LLC | — | Sale | 153,078 @ $3.00 | 2,105,909 | Jul 31, 2023 |
| OrbiMed Capital GP VII LLC | — | Sale | 4,700 @ $2.92 | 909,567 | Jul 25, 2023 |
| OrbiMed Advisors Israel II Ltd | — | Sale | 52,800 @ $2.40 | 914,267 | Jul 13, 2023 |
| ORBIMED ADVISORS LLC | — | Sale | 660 @ $1.97 | 179,753 | Apr 13, 2023 |